Pollen Allergy Vaccine: Why the WHO Endorsed the Term and What It Actually Means
Pollen allergy vaccine combines a pollen-specific frame with the vaccine terminology endorsed by the 1998 WHO position paper (Bousquet, Lockey, Malling — PMID 9802362). In the US, this refers to either SCIT injections of pollen extract (3-5 year course per Cox 2011) or FDA-approved SLIT tablets — Grastek (Timothy grass), Oralair (5-grass mix), Ragwitek (short ragweed). This is NOT a one-time shot like MMR; the minimum course is 3 years for durable remission per Durham 1999 NEJM.
6 peer-reviewed sources
Pollen allergy vaccine refers to allergen immunotherapy for pollen-allergic patients — subcutaneous SCIT injections or FDA-approved sublingual tablets (Grastek, Oralair, Ragwitek). Endorsed as 'allergen vaccine' by WHO 1998 (PMID 9802362). Not a one-time shot — a 3-5 year course.
The essentials
Pollen allergy vaccine is a medically legitimate term — not a lay misconception — because it was explicitly endorsed by the 1998 WHO position paper: Bousquet J, Lockey R, Malling HJ. 'Allergen immunotherapy: therapeutic vaccines for allergic diseases.' J Allergy Clin Immunol 1998;102(4 Pt 1):558-562 (PMID 9802362). The WHO paper retitled allergen extracts as 'allergen vaccines' to reflect their immune-modifier mechanism — similar to how infectious-disease vaccines train the immune system, but through a different pathway (Treg induction rather than antibody-mediated immunity). European allergy literature and international patients use this terminology more readily than US clinicians, who prefer 'immunotherapy' to avoid one specific confusion: the expectation that a vaccine means one or two doses and then decades of protection, like an MMR or DTaP.
The pollen-specific component maps to specific products. For subcutaneous immunotherapy (SCIT), the pollen-extract options include 9 FDA-standardized grass extracts (Anthoxanthum odoratum, Cynodon dactylon, Dactylis glomerata, Festuca elatior, Lolium perenne, Phleum pratense, Poa pratensis, Sorghum halepense, Holcus lanatus) and short ragweed (Ambrosia artemisiifolia) — these have calibrated biological activity units per FDA CBER. Tree pollen extracts (oak, birch, maple, ash, mountain cedar) are non-standardized and mixed in weight-to-volume ratios. For sublingual immunotherapy, four FDA-approved pollen tablet products exist: Grastek (Phleum pratense/Timothy grass, Merck/ALK, ages 5-65); Oralair (5-grass mix, Stallergenes Greer, ages 5-65); and Ragwitek (short ragweed Ambrosia artemisiifolia, Merck, age 5+).
The evidence for pollen SCIT is among the strongest in all immunotherapy. Durham SR et al (NEJM 1999;341:468-475) showed that a 3-year grass-pollen SCIT course produced 4 additional symptom-free years after discontinuation. Creticos PS et al (NEJM 1996) demonstrated ragweed SCIT efficacy in a landmark RCT. Cochrane meta-analysis (Calderón 2007, 51 RCTs) found symptom SMD -0.73 — the majority of included trials were pollen-SCIT studies.
Curex offers at-home IgE testing with allergist review to identify which specific pollens drive symptoms — distinguishing grass from tree from ragweed sensitization is required before any pollen-immunotherapy decision under Cox 2011.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
Pollen-specific SCIT and SLIT have the strongest evidence base among all allergen categories. The foundational pollen studies underpin most immunotherapy guidelines worldwide.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Pollen-allergic patients have the widest range of evidence-based immunotherapy options, including both injectable SCIT and FDA-approved SLIT tablet products for specific pollen categories.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (Curex SCIT, pollen) | |||||
Grastek / Oralair (grass SLIT tablets) | |||||
Ragwitek (ragweed SLIT tablet) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For pollen-allergic patients who want the injection course without the clinic schedule, Curex delivers SCIT as one weekly shot you give yourself at home for $129/month — a personalized pollen-extract serum sterile-compounded to USP <797>, prescribed by a board-certified allergist, with your first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand.
See if at-home shots are right for youFrequently asked questions
Is there a vaccine for pollen allergies?
Yes — but it is not a one-time shot. The WHO 1998 position paper (Bousquet J, Lockey R, Malling HJ, JACI 1998;102:558-562, PMID 9802362) formally endorsed calling allergen extracts 'therapeutic vaccines for allergic diseases.' In practice, pollen allergy vaccination means a 3-to-5-year course of subcutaneous immunotherapy (SCIT) using pollen extract injections, or FDA-approved sublingual tablet products — Grastek or Oralair for grass pollen, Ragwitek for ragweed. A complete course produces 4-12 years of durable post-treatment remission per Durham 1999 NEJM — significantly more durable than conventional medication, but not a single-dose lifetime solution like childhood vaccines.
What are the FDA-approved pollen allergy tablets (SLIT)?
Four FDA-approved sublingual immunotherapy tablets target pollen: Grastek (Phleum pratense/Timothy grass; Merck under license from ALK-Abelló; approved for ages 5-65); Oralair (5-grass mix including Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue; Stallergenes Greer; approved ages 5-65); and Ragwitek (short ragweed Ambrosia artemisiifolia; Merck; age range expanded to 5+ in 2021). Odactra is a fourth approved SLIT tablet but targets house dust mite, not pollen. All three pollen tablets carry a boxed warning for severe anaphylaxis and laryngopharyngeal reactions; the first dose must be supervised by a physician with epinephrine available, and patients must be prescribed an epinephrine auto-injector.
How does pollen immunotherapy differ from a flu shot?
A flu shot is a traditional vaccine: it delivers inactivated or recombinant influenza antigens that trigger protective IgG antibodies over 2-4 weeks, providing season-long (approximately 6-month) protection through antibody-mediated immunity. Pollen immunotherapy is a multi-year tolerance-induction course that works through regulatory T cells (Tregs), blocking IgG4 antibodies, and suppression of Th2 inflammation — a different immune mechanism from infectious-disease vaccine-induced immunity. Pollen immunotherapy takes 3-5 years to complete (not 2 weeks for protection) and requires maintenance-level dosing, but produces benefits that persist for years after stopping — no flu shot provides this multi-year durability.
Which grass pollen extracts are FDA-standardized for allergy shots?
Nine grass species are on the FDA CBER standardized allergenics list: Anthoxanthum odoratum (Sweet Vernal), Cynodon dactylon (Bermuda grass), Dactylis glomerata (Orchard grass), Festuca elatior (Meadow fescue), Lolium perenne (Perennial ryegrass), Phleum pratense (Timothy grass), Poa pratensis (Kentucky bluegrass), Sorghum halepense (Johnson grass), and Holcus lanatus (Velvet grass). These extracts have calibrated potency in biological activity units (BAU). Short ragweed (Ambrosia artemisiifolia) is also FDA-standardized. Tree pollen extracts — oak, birch, maple, ash, mountain cedar — are non-standardized and measured in protein nitrogen units or weight-to-volume ratios.
Can pollen allergy immunotherapy prevent asthma?
Pollen SCIT has the strongest evidence for asthma prevention of any allergy intervention. The Preventive Allergy Treatment (PAT) study (Jacobsen L et al, Allergy 2007;62:943-948) followed children with allergic rhinitis treated with 3-year pollen SCIT versus pharmacotherapy and found that the SCIT group had approximately half the rate of asthma development at 10-year follow-up. Möller C et al (JACI 2002) confirmed the signal at 3-year follow-up within the same study. No antihistamine, nasal corticosteroid, or biologic injection has demonstrated comparable asthma-prevention data. This pediatric benefit is one of the strongest arguments for early pollen immunotherapy initiation in allergic-rhinitis children.
Is pollen allergy immunotherapy available without injections?
Yes. Three FDA-approved sublingual tablet products cover grass and ragweed pollen: Grastek (Timothy grass), Oralair (5-grass mix), and Ragwitek (short ragweed). All are daily dissolving tablets taken under the tongue at home after a supervised first dose. For patients with sensitization to tree pollens or unusual grass species not covered by the FDA tablet products, off-label sublingual drops with custom pollen extract formulations are another needle-free option. Tree pollen SLIT drops are not FDA-approved as finished products but use the same allergen extract manufacturers that supply SCIT and are prescribed off-label by many allergists.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Exposure Therapy: Safe vs Unsafe | Curex
Allergy exposure therapy = SCIT or SLIT: controlled escalating allergen doses under allergist care inducing tolerance. Unsupervised exposure is dangerous.
Read moreAllergy Shot Names: Complete Naming Guide | Curex
Allergy shot names: SCIT, AIT, hyposensitization, allergy vaccine (WHO 1998). Brand names belong to SLIT tablets, biologics, and steroids — not SCIT.
Read moreAllergy Shots for Cats (Humans) | Curex SCIT Guide
Allergy shots for cats target Fel d 1 for HUMANS, not the pet. 23.9% quit conventional SCIT (Tkacz 2021). Curex delivers that SCIT at home, $129/mo.
Read moreAllergy Desensitization: SCIT Guide & History | Curex
Allergy desensitization is the historical term for SCIT (allergen immunotherapy). Cochrane 51 RCTs: SMD -0.73. Learn the terminology shift from 1911 to today.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.